SCHEMBL6439358

SCHEMBL6439358

[CH2]c1cccc(-c2ccc(CO)o2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.65
MAPT P10636 5/20 0.65
KDM4E B2RXH2 4/20 0.65
CYP2A6 P11509 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.49
POLB P06746 2/20 0.43
TP53 P04637 1/20 0.43
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP2E1 P05181 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2B6 P20813 2/20 0.42
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
HTT P42858 2/20 0.41
SOS1 Q07889 1/20 0.41
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623853 0.79 ALDH1A1 (0.65) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL11361854 0.79 ALDH1A1 (0.65) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL31412159 0.79 ALDH1A1 (1.00) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL12876582 0.79 ALDH1A1 (0.65) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL624093 0.79 ALDH1A1 (0.65) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL24721067 0.75 ALDH1A1 (0.59) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL1198267 0.75 KDM4E (0.59) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL24304833 0.73 ALDH1A1 (0.55) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL8411578 0.71 ALDH1A1 (0.53) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2
SCHEMBL28154714 0.70 ALDH1A1 (0.54) ALDH1A1MAPTKDM4ECYP2A6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492567-A1 FORMULATIONS AND METHODS OF USING NITRIC OXIDE MIMETICS IN CANCER TREATMENT Cellegy Pharmaceuticals, Inc (US) 2005-01-05 EP disclosed
WO-2003074082-A1 FORMULATIONS AND METHODS OF USING NITRIC OXIDE MIMETICS IN CANCER TREATMENT CELLEGY PHARMACEUTICALS, INC. (CA) 2003-09-12 WO disclosed